No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta
Resource Type
Article
Authors
Hollnberger, Julius ; Liu, Yang ; Xu, Simin ; Chang, Silvia ; Martin, Ross ; Manhas, Savrina ; Aeschbacher, Thomas ; Han, Bin ; Yazdi, Tahmineh ; May, Lindsey ; Han, Dong ; Shornikov, Alex ; Flaherty, John ; Manuilov, Dmitry ; Suri, Vithika ; Asselah, Tarik ; Lampertico, Pietro ; Wedemeyer, Heiner ; Aleman, Soo ; Richards, Christopher ; Mateo, Roberto ; Maiorova, Evguenia ; Cihlar, Tomas ; Mo, Hongmei ; Urban, Stephan
Source
In Journal of Hepatology September 2023 79(3):657-665
Subject
Viral Hepatitis
Language
ISSN
0168-8278